313 related articles for article (PubMed ID: 31385465)
1. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
[TBL] [Abstract][Full Text] [Related]
2. Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
Cao G; Liu J; Liu M
J Epidemiol Glob Health; 2023 Jun; 13(2):344-360. PubMed ID: 37178451
[TBL] [Abstract][Full Text] [Related]
3. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.
Liu Z; Jiang Y; Yuan H; Fang Q; Cai N; Suo C; Jin L; Zhang T; Chen X
J Hepatol; 2019 Apr; 70(4):674-683. PubMed ID: 30543829
[TBL] [Abstract][Full Text] [Related]
4. [Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].
Zhu S; Chen ST; Jin YY; Lu SW; Zou FJ; Ma WJ; Zeng FF; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):185-191. PubMed ID: 38413055
[No Abstract] [Full Text] [Related]
5. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
Cao G; Liu J; Liu M
Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
[TBL] [Abstract][Full Text] [Related]
6. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
[TBL] [Abstract][Full Text] [Related]
7. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.
Zhai M; Long J; Liu S; Liu C; Li L; Yang L; Li Y; Shu B
Aging (Albany NY); 2021 Jan; 13(1):279-300. PubMed ID: 33436531
[TBL] [Abstract][Full Text] [Related]
8. Comparison of time trends in the incidence of primary liver cancer between China and the United States: an age-period-cohort analysis of the Global Burden of Disease 2019.
Zou Z; Zhang Z; Lu C; Wang H
Chin Med J (Engl); 2022 Sep; 135(17):2035-2042. PubMed ID: 36103990
[TBL] [Abstract][Full Text] [Related]
9. Attributable causes of liver cancer mortality and incidence in china.
Fan JH; Wang JB; Jiang Y; Xiang W; Liang H; Wei WQ; Qiao YL; Boffetta P
Asian Pac J Cancer Prev; 2013; 14(12):7251-6. PubMed ID: 24460283
[TBL] [Abstract][Full Text] [Related]
10. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status.
Cao G; Jing W; Liu J; Liu M
Hepatol Int; 2022 Dec; 16(6):1282-1296. PubMed ID: 36048317
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomics and attributable etiology of primary liver cancer, 1990-2019.
Xing QQ; Li JM; Dong X; Zeng DY; Chen ZJ; Lin XY; Pan JS
World J Gastroenterol; 2022 Jun; 28(21):2361-2382. PubMed ID: 35800181
[TBL] [Abstract][Full Text] [Related]
12. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.
Liu Z; Suo C; Mao X; Jiang Y; Jin L; Zhang T; Chen X
Cancer; 2020 May; 126(10):2267-2278. PubMed ID: 32201944
[TBL] [Abstract][Full Text] [Related]
13. HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease.
Rajbhandari R; Danford CJ; Chung RT; Ananthakrishnan AN
Aliment Pharmacol Ther; 2015 May; 41(10):928-38. PubMed ID: 25786514
[TBL] [Abstract][Full Text] [Related]
14. The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.
Li Y; Ou Z; Yu D; He H; Zheng L; Chen J; Chen C; Xiong H; Chen Q
BMC Cancer; 2023 Jun; 23(1):598. PubMed ID: 37380957
[TBL] [Abstract][Full Text] [Related]
15. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
Huang DQ; Singal AG; Kono Y; Tan DJH; El-Serag HB; Loomba R
Cell Metab; 2022 Jul; 34(7):969-977.e2. PubMed ID: 35793659
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
17. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
Yao L; Lin S; Huang J; Wu Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
[TBL] [Abstract][Full Text] [Related]
18. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017.
Zheng L; Cui C; Shi O; Lu X; Li YK; Wang W; Li Y; Wang Q
Gynecol Oncol; 2020 Oct; 159(1):239-247. PubMed ID: 32690392
[TBL] [Abstract][Full Text] [Related]
19. Trends in the disease burden of HBV and HCV infection in China from 1990-2019.
Yue T; Zhang Q; Cai T; Xu M; Zhu H; Pourkarim MR; De Clercq E; Li G
Int J Infect Dis; 2022 Sep; 122():476-485. PubMed ID: 35724827
[TBL] [Abstract][Full Text] [Related]
20. The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017.
Li C; He WQ
Liver Int; 2021 Aug; 41(8):1762-1774. PubMed ID: 33590659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
